黄色视频不卡_午夜福利免费观看在线_亚洲国产精品999在线_欧美绝顶高潮抽搐喷水_久久精品成人免费网站_晚上一个人看的免费电影_国产又色又爽无遮挡免费看_成人国产av品久久久

    1. <dd id="lgp98"></dd>
      • <dd id="lgp98"></dd>
        1. 上海復祥生物科技有限公司

          當前位置:> 供求商機> CLHKGR02-美國人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細胞株(線粒體表達)

          [供應]CLHKGR02-美國人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細胞株(線粒體表達)

          貨物所在地:上海上海市

          產(chǎn)地:美國PrimCells

          更新時間:2024-10-10 21:00:07

          有效期:2024年10月10日 -- 2025年4月10日

          已獲點擊:160

          聯(lián)系我時,請告知來自 化工儀器網(wǎng)

          美國Human Glucocorticoid Receptor Stable Cells (Mitochondria Specific)
          美國人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細胞株(線粒體表達)
          美國PrimCells誘導性穩(wěn)定細胞株: PrimCells建立的*的誘導性細胞高效開發(fā)系統(tǒng),能在極短時間內(nèi)篩選出低泄漏,高誘導性的穩(wěn)定細胞株,成功開發(fā)出一系列核受體誘導表達的穩(wěn)定細胞

          美國人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細胞株(線粒體表達)
          美國PrimCells誘導性穩(wěn)定細胞株: PrimCells建立的*的誘導性細胞高效開發(fā)系統(tǒng),能在極短時間內(nèi)篩選出低泄漏,高誘導性的穩(wěn)定細胞株,成功開發(fā)出一系列核受體誘導表達的穩(wěn)定細胞株產(chǎn)品,為多家制藥公司研發(fā)部門和科研院所提供產(chǎn)品與服務,廣受用戶好評。針對客戶的特定需求,PrimCells亦提供量身定制服務,通過密切的客戶交流和高效的篩選體系,嚴格保證客戶在3-4周內(nèi)即獲得高質(zhì)量的誘導性穩(wěn)定細胞株,具有市場其他供應商*的時效性。
          Introduction:

          Nuclear hormone receptors (NHRs) are a superfamily of transcription factors that function as powerful metabolic regulators to control a variety of systemic processes in physiology. They also play key roles in the pathophysiology of many major disease states, such as diabetes, obesity, inflammation, atherosclerosis and heart failure. To date, this superfamily has provided a rich source of drug design targets and it is continuing to be one of the hottest areas for pharmaceutical research.

          PrimCells now provides a comprehensive set of NHR expressing cell lines to the research community. These high-quality, Flag and/or HA-tagged NHR-expressing cell lines aim to facilitate further biochemical and molecular studies of their functions and hence encourage new strategies for drug design.

          Glucocorticoids (GCs) are steroid hormones that allow us to cope with environmental and physiological stresses. Although GCs are widely used as anti-inflammatory agents in several clinical areas, long-term use of those steroids causes problems instead. Full achievement of the clinical potential of GCs necessitates limiting the side effects of these drugs.

          The lipophilic nature of GCs allows them to readily diffuse into the cells, where they bind to a cytosolic receptor, the Glucocorticoid Recetpor (GR) to exert their mechanism of action. Without ligand binding, GR is predominantly localized in cytoplasm, whereas upon ligand binding it rapidly translocates to nucleus where it can both positively and negatively regulate gene expression. GR belongs to the nuclear receptor superfamily of ligand-activated transcription factors that function as powerful metabolic regulators. Several studies have shown that GR also translocates to the mitochondrial in addition to its nuclear translocation in response to GC treatment. The mitochondrial GR translocation has been shown to be positively correlated with GC-induced apoptosis, although the mechanism is unclear.

          The mitochondrial-specific GR (Flag and HA tagged)/HEK293 cell line was created by stable transfection of HEK293 cells with a plasmid expressing Flag and HA tagged GR protein with a mitochondrial localization signal.


          美國PrimCells品牌介紹
          PrimCells是位于美國加州圣迭戈的一家專業(yè)致力于細胞產(chǎn)品研發(fā)和解決方案提供的業(yè)內(nèi)技術。
          公司匯集了*的生物醫(yī)藥技術專家,獨立開發(fā)了多項原代細胞和干細胞相關的專有技術。 公司以“細胞研究的*選擇”為宗旨,自主研發(fā)超過70種創(chuàng)新產(chǎn)品,*多個特種細胞市場的空白。例如其誘導性表達細胞庫和高效3D皮膚培養(yǎng)系統(tǒng),皆為該類產(chǎn)品目前市場上少數(shù)的規(guī)?;?。此外,公司以高質(zhì)量的數(shù)據(jù)與快速穩(wěn)定的項目完成時間,長期為多家制藥公司提供解決方案,獲得用戶廣泛贊譽。   
          PrimCells產(chǎn)品線:

          • 報告基因干細胞        2. 原代細胞(含報告基因原代細胞)               3. 誘導性穩(wěn)定細胞株

          4. 人源重組蛋白               5.   創(chuàng)新型培養(yǎng)試劑      
          PrimCells 解決方案
          1.誘導性穩(wěn)定細胞株開發(fā) 2. 原代細胞開發(fā) 3. 藥物體外毒理和效能測試 4. 3D-皮膚培養(yǎng)
          PrimCells合作伙伴及客戶:
          A.生物制藥公司:輝瑞(Pfizer), 諾華(Novartis), 禮來(Eli2  Lilly),. Amgen, EMD Millipore, Regeneron等公司的毒理和醫(yī)藥研發(fā)部門
          B.科研機構(gòu):冷泉港實驗室,哈佛醫(yī)學院, 麻省理工(MIT),, UCSF, NYU, Salk, UIUC, USC等

          會員登錄

          X

          請輸入賬號

          請輸入密碼

          =

          請輸驗證碼

          收藏該商鋪

          X
          該信息已收藏!
          標簽:
          保存成功

          (空格分隔,最多3個,單個標簽最多10個字符)

          常用:

          提示

          X
          您的留言已提交成功!我們將在第一時間回復您~

          以上信息由企業(yè)自行提供,信息內(nèi)容的真實性、準確性和合法性由相關企業(yè)負責,化工儀器網(wǎng)對此不承擔任何保證責任。

          溫馨提示:為規(guī)避購買風險,建議您在購買產(chǎn)品前務必確認供應商資質(zhì)及產(chǎn)品質(zhì)量。

          撥打電話
          在線留言
          武夷山市| 石渠县| 上高县| 忻州市| 托克逊县| 合川市| 乐亭县| 阿克苏市| 青龙| 鄂州市| 镇原县| 阿图什市| 乃东县| 金山区| 江阴市| 平乡县| 印江| 江达县| 文安县| 庆阳市| 水城县| 醴陵市| 拉萨市| 玛多县| 绥德县| 丰城市| 紫阳县| 缙云县| 高碑店市| 沁水县| 洪湖市| 望都县| 昭觉县| 鸡东县| 武宣县| 元江| 平乐县| 新河县| 镇原县| 兴山县| 石家庄市|